£43.00

It has never been this cheap. We have no record of a lower price.

£43 today · cheaper than every other day in the last 3 months

LAP Lambert Academic Publishing Neutropenia and Its Management in Cancer Patients on Chemotherapy

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 73 days · 73 data points (no recent data)

Historical
Generating forecast…
£43.00 £40.85 £41.71 £42.57 £43.43 £44.29 £45.15 23 August 2026 10 September 2026 28 September 2026 16 October 2026 03 November 2026
View at Amazon ↗

Price data last checked 18 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 73 days • 1 price levels

Days at Price
73 days 0 18 37 55 73 £43 Days at Price

Price Analysis

Most common price: £43 (73 days, 100.0%)

Price range: £43 - £43

Price levels: 1 different prices over 73 days

Description

This book provides guidance to oncologists responsible for reducing neutropenia and its management in cancer patients on chemotherapy. Evaluating results from the study and performing risk assessments associated with neutropenia, will be particularly useful to physicians to choose the right kind of treatment in reducing neutropenia. This study presents insights into future directions of oncology field into right kind of treatment in different modalities of cancer patients with solid tumors and lymphoma. Neutropenia is an important side effects and a major cause of morbidity and mortality in patients with cancer. The risk of infection is related to the intensity and duration of immunosuppressive chemotherapy. Various types of growth factors and cyto-protectant can be combined with the goal of increasing efficacy of chemo drugs and reducing different types of toxicities. In this text we have compared the efficacy of growth factor and cyto-protectant drug, randomly and cross over. This text can provide insight to the consultants to design that cyto-protectant drug administration followed by growth factors is beneficial treatment to reduce the complications of cancer chemotherapy

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
06 February 2017
Listed Since
01 March 2017

Barcode

No barcode data available

Similar Products You Might Like

New Purine Nucleosides in Cancer Chemotherapy
81% match

New Purine Nucleosides in Cancer Chemotherapy

LAP Lambert Academic Publishing

£73.00 04 Nov 2026
Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide
81% match

Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide

Springer

£84.04 21 Oct 2026
Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML
80% match

Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML

CREATESPACE

£45.99 22 Oct 2026
Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)
80% match

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Humana

£80.67 23 Oct 2026
Childhood Acute Lymphoblastic Leukemia
80% match

Childhood Acute Lymphoblastic Leukemia

Springer

£92.00 24 Oct 2026
Supportive Care in Pediatric Oncology: A Practical Evidence-Based Approach
80% match

Supportive Care in Pediatric Oncology: A Practical Evidence-Based Approach

Springer

£126.93 27 Oct 2026
Cancer Metabolism and Natural Management: Human Cancer Metabolism: Etiology, Progression, Complications and Medicinal Plants Prevention and Treatments of cancer
79% match

Cancer Metabolism and Natural Management: Human Cancer Metabolism: Etiology, Progression, Complications and Medicinal Plants Prevention and Treatments of cancer

LAP Lambert Academic Publishing

£73.00 07 Nov 2026
Genetic Changes and Their Prognostic Impact In Leukaemia Patients: Characterization of Cytogenetic and Molecular Genetic Changes and Their Prognostic impact in Acute Leukaemia Patients
79% match

Genetic Changes and Their Prognostic Impact In Leukaemia Patients: Characterization of Cytogenetic and Molecular Genetic Changes and Their Prognostic impact in Acute Leukaemia Patients

LAP Lambert Academic Publishing

£61.00 07 Nov 2026
Nutritional Management of Cancer Treatment Effects
79% match

Nutritional Management of Cancer Treatment Effects

Springer

£80.65 27 Oct 2026
Chronic Myeloid Leukemia (Hematologic Malignancies)
79% match

Chronic Myeloid Leukemia (Hematologic Malignancies)

Springer

£109.97 23 Oct 2026
Metronomic Chemotherapy: Pharmacology and Clinical Applications
78% match

Metronomic Chemotherapy: Pharmacology and Clinical Applications

Springer

£83.72 23 Oct 2026
Complications of Cancer Therapy: Best Practices in Prevention and Management
78% match

Complications of Cancer Therapy: Best Practices in Prevention and Management

Springer

£52.80 26 Oct 2026
Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide
78% match

Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide

Springer

£98.27 27 Oct 2026
Bridging the Gap: In This Era of Cancer Immunotherapy (Cancer Etiology, Diagnosis and Treatments)
78% match

Bridging the Gap: In This Era of Cancer Immunotherapy (Cancer Etiology, Diagnosis and Treatments)

Price unavailable
Oncologic Therapies
78% match

Oncologic Therapies

Springer

£81.74 23 Oct 2026
Immunotherapy for Pediatric Malignancies
78% match

Immunotherapy for Pediatric Malignancies

Springer

£113.90 26 Oct 2026
Enzyme-Prodrug Strategies for Cancer Therapy
78% match

Enzyme-Prodrug Strategies for Cancer Therapy

Springer

£149.87 23 Oct 2026
Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider
78% match

Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider

Springer

£89.78 21 Oct 2026
Biologic Therapy of Leukemia (Contemporary Hematology)
78% match

Biologic Therapy of Leukemia (Contemporary Hematology)

Humana

£73.35 04 Nov 2026
Patient Safety and Quality in Pediatric Hematology/Oncology and Stem Cell Transplantation
78% match

Patient Safety and Quality in Pediatric Hematology/Oncology and Stem Cell Transplantation

Springer

£69.40 29 Oct 2026
Nutraceuticals and Cancer
78% match

Nutraceuticals and Cancer

Springer

£113.76 23 Oct 2026
Chemokines and Cancer (Contemporary Cancer Research)
78% match

Chemokines and Cancer (Contemporary Cancer Research)

Humana

£128.14 24 Oct 2026
The added value of natural killer cells in immunotherapy for leukemia: Triggering natural killer cell functions with a dsRNA-transfected tumor cell vaccine
78% match

The added value of natural killer cells in immunotherapy for leukemia: Triggering natural killer cell functions with a dsRNA-transfected tumor cell vaccine

LAP Lambert Academic Publishing

£62.00 04 Nov 2026
Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies
78% match

Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies

Elsevier

£141.99 23 Oct 2026